Acne pill benefits outweigh blood clot risk: EU agency (AFP, 18 May 2013)

20 May 2013


The Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (EMA) has announced its recommendations following a safety review of Diane 35 and its generics.

Full article

EMA statement


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story